Cutaneous Manifestations in Patients with SARS-CoV-2 Infections

Acta Dermatovenerol Croat. 2022 Dec;30(4):216-219.

Abstract

While SARS-CoV-2 is known to cause pneumonia and acute respiratory distress syndrome (ARDS), many extrapulmonary manifestations of COVID-19 have also been observed. Cutaneous manifestations including erythematous rash, urticaria, and chickenpox-like vesicles have been described in patients with SARS-CoV-2. Six patients, two men and four women, in the age group of 50 to 60 years old, hospitalized with SARS-CoV-2 infection confirmed with real-time polymerase chain reaction (real-time PCR) presented cutaneous manifestations. The rash was confluent, spotty, centrifugal, and non-itchy on the head and torso. It was not hemorrhagic, and no crust or blisters were observed. The results of laboratory tests were normal, and the rash disappeared on its own. Several cases of cutaneous manifestations have been reported in patients with SARS-CoV-2 infection. Further studies are needed in order to assess the skin lesions and determine their association with COVID-19.

MeSH terms

  • Blister
  • COVID-19* / complications
  • Exanthema* / complications
  • Female
  • Humans
  • Male
  • Middle Aged
  • SARS-CoV-2
  • Skin Diseases* / complications
  • Urticaria*